XFOR

X4 Pharmaceuticals, Inc. Common Stock

3.43

USD

-0.06

-1.86%

Sep 22, 15:59 UTC -4

Closed

Pre-Market

3.48

+0.04

+1.31%

X4 Pharmaceuticals, Inc. Common Stock Profile

About

X4 Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of novel therapeutics for the treatment of rare diseases. The company's product candidates include X4P-001, X4P-002 and X4P-003 which are in clinical stage. X4 Pharmaceuticals Inc., formerly known as Arsanis, Inc., is based in Cambridge, United States.

Info & Links

CEO

Adam R. Craig

Headquarters

61 North Beacon Street, 4th Floor
Boston, MA 02134, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

X4 Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

344.53M

Enterprise Value

226.20M

Enterprise Value/EBITDA(ttm)

-2.62

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

22.40

Price to Book(mrq)

2.17

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

81.37%

Operating Margin(ttm)

-568.80%

Profit Margin(ttm)

-887.96%

Return on Equity(ttm)

-63.05%

Return on Invested Capital(ttm)

-45.99%

Return on Assets(ttm)

-36.89%

Income Statement

Revenue(ttm)

15.85M

Revenue Per Share(ttm)

0.16

Gross Profit(ttm)

12.92M

EBITDA(ttm)³

-86.24M

Net Income Available to Common(ttm)

-90.14M

Diluted EPS(ttm)

-1.20

Share Statistics

Beta (5Y Monthly)

0.39

52-Week Change

1.48%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

99.15M

Dividend Yield

0.00%

Float⁴

98.03M

% Held by Insiders

1.13%

% Held by Institutions

72.03%

Balance Sheet

Total Cash(mrq)

207.97M

Total Cash Per Share(mrq)

2.10

Total Debt(mrq)

76.76M

Total Debt/Equity(mrq)

49.38%

Current Ratio(mrq)

11.30%

Quick Ratio(mrq)

11.02%

Book Value Per Share(mrq)

1.62

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.32

Free Cash Flow(ytd)

-40.39M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.